benefits of Siddha medicines in covid-19 positive patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/08/027491
- Lead Sponsor
- District Administration
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Adult Male/Female subjects above the age of 18 years
COVID -19 Positive as determined by RT-PCR
Willing to provide written/digital informed consent.
COVID - 19 Positive with no clinical signs
COVID - 19 Positive with mild symptoms â?? Sneezing, Cough, Sore Throat, Throat Pain, Malaise, Tiredness, Fever, loss of smell, loss of taste
COVID - 19 Positive with moderate symptoms â?? Fever with cough, breathlessness but respiratory rate <24 per minute and Oxygen saturation > 95% at rest
Pregnant and Lactating females
COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation < 95% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non respiratory organ failure
Chronic Renal Failure requiring dialysis (eGFR < 30)
Known cases of uncontrolled Diabetes ( >9% HbA1c)
Known cases of stage 3 Hypertension ( > 160/100 mmHg)
Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.
Subjects taking Steroid treatment and or any kind of immunosuppressive therapy
Subjects who are participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
Subjects with bleeding disorders and severe anemia (Hb <7 g/dL)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method